An Open-Label Study of Oral Antipsychotics Replacement by Prolonged Release Risperidone (Risperdal Consta) in Schizophrenic Subjects With Bad Adhesion to the Treatment
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Risperidone (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- Sponsors Janssen-Cilag
- 09 Jan 2013 Actual initiation date changed from Dec 2005 to Jan 2006 as reported by ClinicalTrials.gov.
- 14 Dec 2012 New trial record